Jack L. Harbert

2.2k total citations · 1 hit paper
5 papers, 1.1k citations indexed

About

Jack L. Harbert is a scholar working on Infectious Diseases, Oncology and Molecular Biology. According to data from OpenAlex, Jack L. Harbert has authored 5 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Jack L. Harbert's work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Histiocytic Disorders and Treatments (1 paper). Jack L. Harbert is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Histiocytic Disorders and Treatments (1 paper). Jack L. Harbert collaborates with scholars based in United States and Taiwan. Jack L. Harbert's co-authors include J. Quincy Brown, Sharon Fox, Richard S. Vander Heide, Guang Li, Guang Li, James W. Janc, Steven L. Barriere, Eduardo Candelario‐Jalil, Mark A. Atkinson and Verena van der Heide and has published in prestigious journals such as Circulation, American Journal of Clinical Pathology and The Lancet Respiratory Medicine.

In The Last Decade

Jack L. Harbert

4 papers receiving 1.1k citations

Hit Papers

Pulmonary and cardiac pathology in African American patie... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack L. Harbert United States 3 911 474 240 141 124 5 1.1k
Jasmin D. Haslbauer Switzerland 11 918 1.0× 491 1.0× 273 1.1× 99 0.7× 85 0.7× 24 1.3k
Daniel Turek Switzerland 4 657 0.7× 359 0.8× 198 0.8× 77 0.5× 29 0.2× 4 860
Mara Falco Italy 5 586 0.6× 335 0.7× 271 1.1× 184 1.3× 31 0.3× 7 823
Fien A. von Meijenfeldt Netherlands 13 430 0.5× 212 0.4× 79 0.3× 94 0.7× 44 0.4× 17 863
Panagiota Gianni Germany 5 494 0.5× 238 0.5× 140 0.6× 104 0.7× 17 0.1× 5 681
Klaus Vander Austria 5 462 0.5× 232 0.5× 164 0.7× 116 0.8× 30 0.2× 7 593
Nicole Yarid United States 7 510 0.6× 265 0.6× 105 0.4× 19 0.1× 39 0.3× 12 717
Louise Bowles United Kingdom 12 293 0.3× 154 0.3× 62 0.3× 123 0.9× 91 0.7× 18 804
Nadin Elsayed United States 9 294 0.3× 191 0.4× 141 0.6× 133 0.9× 183 1.5× 42 652
Bingwen Eugene Fan Singapore 14 266 0.3× 213 0.4× 48 0.2× 63 0.4× 46 0.4× 66 643

Countries citing papers authored by Jack L. Harbert

Since Specialization
Citations

This map shows the geographic impact of Jack L. Harbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Harbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Harbert more than expected).

Fields of papers citing papers by Jack L. Harbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. Harbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Harbert. The network helps show where Jack L. Harbert may publish in the future.

Co-authorship network of co-authors of Jack L. Harbert

This figure shows the co-authorship network connecting the top 25 collaborators of Jack L. Harbert. A scholar is included among the top collaborators of Jack L. Harbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack L. Harbert. Jack L. Harbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Harbert, Jack L., et al.. (2022). Eosinophilic Solid and Cystic Renal Cell Carcinoma with Non-typical Immunophenotype: A Series of Two Cases. American Journal of Clinical Pathology. 158(Supplement_1). S75–S76.
2.
Fox, Sharon, et al.. (2020). Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. The Lancet Respiratory Medicine. 8(7). 681–686. 977 indexed citations breakdown →
3.
Kusmartseva, Irina, Wenting Wu, Farooq Syed, et al.. (2020). ACE2 and SARS-CoV-2 Expression in the Normal and COVID-19 Pancreas. SSRN Electronic Journal. 1 indexed citations
4.
Fox, Sharon, et al.. (2020). Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation. 142(11). 1123–1125. 116 indexed citations
5.
Harbert, Jack L., et al.. (2013). Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers. Journal of Thrombosis and Thrombolysis. 38(2). 235–240. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026